keyword
https://read.qxmd.com/read/38610910/the-impact-of-tumor-laterality-unilateral-vs-bilateral-on-presentation-and-management-outcome-in-patients-with-retinoblastoma
#1
JOURNAL ARTICLE
Mona Mohammad, Mustafa Mehyar, Hadeel Halalsheh, Reham Shehada, Omar Al Adawi, Jakub Khzouz, Imad Jaradat, Maysa Al-Hussaini, Iyad Sultan, Ibrahim Alnawaiseh, Yacoub A Yousef
Background: This study compares the outcomes of managing retinoblastoma between patients with unilateral and bilateral presentations. Methods: The study, conducted at the King Hussein Cancer Center in Amman, Jordan, retrospectively analyzed cases of retinoblastoma treated between March 2003 and December 2019. Evaluation criteria included clinical features, disease stage, treatment methods, and overall management outcomes. Results: The study comprised 697 eyes from 478 patients with retinoblastoma, with 52% being males...
April 8, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38554771/nanodrug-modified-with-engineered-cell-membrane-targets-cdks-to-activate-apd-l1-immunotherapy-against-liver-metastasis-of-immune-desert-colon-cancer
#2
JOURNAL ARTICLE
Dongbing Ding, Rongpu Liang, Tan Li, Tianyun Lan, Yiquan Li, Shengxin Huang, Guanhui He, Jiannan Ren, Weibo Li, Zongheng Zheng, Tufeng Chen, Jiafeng Fang, Lijun Huang, Xintao Shuai, Bo Wei
Immunotherapy based on the PD-1/PD-L1 axis blockade has no benefit for patients diagnosed with colon cancer liver metastasis (CCLM) for the microsatellite stable/proficient mismatch repair (MSS/pMMR)) subtype, which is known as an immune-desert cancer featuring poor immunogenicity and insufficient CD8+ T cell infiltration in the tumor microenvironment. Here, a multifunctional nanodrug carrying a cyclin-dependent kinase (CDK)1/2/5/9 inhibitor and PD-L1 antibody is prepared to boost the immune checkpoint blockade (ICB)-based immunotherapy against MSS/pMMR CCLM via reversing the immunosuppressive tumor microenvironment...
March 28, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38492167/epidemiology-diagnosis-and-genetics-of-retinoblastoma-icmr-consensus-guidelines
#3
REVIEW
Lata Singh, Girish Chinnaswamy, Rachna Meel, Venkatraman Radhakrishnan, Renu Madan, Suyash Kulkarni, Archana Sasi, Tanvir Kaur, R S Dhaliwal, Sameer Bakhshi
Retinoblastoma (RB) is the most common intraocular tumor in childhood. It is mainly caused by mutations in both alleles of the RB1 tumor suppressor gene that is found on chromosome 13 and regulates the cell cycle. Approximately 8000 children are diagnosed with RB globally each year, with an estimated 1500 cases occurring in India. The survival rate of RB has improved to more than 90% in the developed world. Leukocoria and proptosis are the most common presenting features of RB in Asian Indian populations. Most cases of RB are diagnosed by fundus examination followed by ultrasound...
March 16, 2024: Indian Journal of Pediatrics
https://read.qxmd.com/read/38481156/strabismus-management-in-retinoblastoma-survivors
#4
JOURNAL ARTICLE
Babak Masoomian, Carol L Shields, Hamid Riazi Esfahani, Atefeh Khalili, Fariba Ghassemi, Pukhraj Rishi, Mohammad Reza Akbari, Masoud Khorrami-Nejad
PURPOSE: To report the result of strabismus surgery in eye-salvaged retinoblastoma (Rb) patients. METHODS: A retrospective case series including 18 patients with Rb and strabismus who underwent strabismus surgery after completing tumor treatment by a single pediatric ophthalmologist. RESULTS: A total of 18 patients (10 females and 8 males) were included with a mean age of 13.3 ± 3.0 (range, 2-39) months at the time tumor presentation and 6...
March 13, 2024: BMC Ophthalmology
https://read.qxmd.com/read/38438837/characteristics-of-patients-with-recurrent-retinoblastoma-a-survival-analysis
#5
JOURNAL ARTICLE
Nan Li, Yi-Zhuo Wang, Yi Zhang, Wei-Ling Zhang, Dong-Sheng Huang
BACKGROUND: Management guidelines and corresponding survival data for patients with recurrent retinoblastoma (RB) are lacking. This study aimed to summarize the clinical characteristics of patients with recurrent RB and analyze their survival outcomes. METHODS: We retrospectively analyzed 68 patients with recurrent RB who underwent treatment in our institution from January 2016 to December 2020. Patients were grouped according to location of recurrence: intraocular, orbital, and distant metastasis...
March 4, 2024: BMC Cancer
https://read.qxmd.com/read/38376084/primary-subretinal-seeding-in-retinoblastoma-clinical-presentation-and-treatment-outcomes
#6
JOURNAL ARTICLE
Komal Bakal, Vishal Raval, Sai Krishna Gattu, Vijay Anand Reddy Palkonda, Swathi Kaliki
INTRODUCTION: The aim of this study was to describe the clinical features and treatment outcomes of primary subretinal seeding (SRS) in patients with intraocular retinoblastoma (RB). METHODS: Descriptive analysis of primary SRS in 47 patients (50 eyes) with RB was performed. RESULTS: Mean age was 19 months (range, 2-72 months), and 55% ( n = 26) of the subjects were male. At presentation, the SRS involved two or more quadrants in 88% of eyes...
August 2023: Ocular Oncology and Pathology
https://read.qxmd.com/read/38332874/retinoblastoma-vulnerability-to-combined-de-novo-and-salvage-pyrimidine-ribonucleotide-synthesis-pharmacologic-blockage
#7
JOURNAL ARTICLE
Tanzina Mollick, Suhas Darekar, Basile Dalarun, Flavia Plastino, Juan Zhang, Andres Pastor Fernández, Twana Alkasalias, Helder André, Sonia Laín
Retinoblastoma is an eye cancer that commonly affects young children. Despite significant advances, current treatments cause side effects even when administered locally, and patients may still have to undergo enucleation. This is particularly disheartening in cases of bilateral retinoblastoma. Hence, there is an urgent need for novel therapeutic strategies. Inhibitors of the enzyme dihydroorotate dehydrogenase (DHODH), which is involved in the de novo pyrimidine ribonucleotide synthesis pathway, have proven to be effective in preclinical trials against several cancers including pediatric cancers...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38300595/circulating-tumor-dna-posttreatment-measurements-and-clinical-correlates-in-retinoblastoma
#8
JOURNAL ARTICLE
David H Abramson, Melissa A Robbins, Y Pierre Gobin, Ira J Dunkel, Jasmine H Francis
IMPORTANCE: Plasma measurements of RB1 circulating tumor DNA (ctDNA) after completion of treatment may be associated with the development of metastases in patients with retinoblastoma. OBJECTIVE: To determine if the absence of previously detectable plasma ctDNA is associated with metastasis-free survival in patients with a minimum of 1 year follow-up after treatment of retinoblastoma. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted from June 2019 to September 2023...
February 1, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38243643/retinoblastoma-treatment-in-a-brazilian-population-presentation-and-long-term-results
#9
JOURNAL ARTICLE
Maria Teresa Brizzi Chizzotti Bonanomi, Maria Tereza A de Almeida, Marianna A Hollaender, Roberta Chizzotti Bonanomi, Mario Luiz Ribeiro Monteiro
INTRODUCTION: Retinoblastoma is a malignant tumor with a high cure potential when proper therapy is used. The purpose of this paper is to report the clinical features and outcomes of patients with retinoblastoma who were treated with a combination of local and systemic chemotherapy-based protocols. METHOD: We retrospectively studied patients treated with systemic chemotherapy plus local treatment between 2003 and 2015 with a follow-up ≥2 years. We correlated clinical and pathological characteristics with decimal visual acuity (VA) and death...
January 19, 2024: Cancer Medicine
https://read.qxmd.com/read/38220428/proteomics-and-genomics-insights-on-malignant-osteosarcoma
#10
REVIEW
Nachammai Kathiresan, Chandrabose Selvaraj, Sangavi Pandian, Gowtham Kumar Subbaraj, Abdulaziz S Alothaim, Sher Zaman Safi, Langeswaran Kulathaivel
Osteosarcoma is a malignant osseous neoplasm. Osteosarcoma is a primary bone malignancy capable of producing osteoid tissue or immature bones. A subsequent malignant degeneration of the primary bone pathology occurs less frequently in adults. The over-expression of several proteins, including Heat shock proteins, Cofilin, Annexins, Insulin-like growth factor, transforming growth factor-β, Receptor tyrosine kinase, Ezrin, Runx2, SATB2, ATF4, Annexins, cofilin, EGFR, VEGF, retinoblastoma 1 (Rb1) and secreted protein, has been associated to the development and progression of osteosarcoma...
2024: Advances in Protein Chemistry and Structural Biology
https://read.qxmd.com/read/38211388/from-diagnosis-to-therapy-the-transformative-role-of-lncrnas-in-eye-cancer-management
#11
REVIEW
Ali Hazazi, Abdulmajid A AlShehah, Farhan R Khan, Mohammed Ageeli Hakami, Fahad Almarshadi, Adil Abalkhail, Somia A Nassar, Hassan H Almasoudi, Amer Al Ali, Mohammed H Abu-Alghayth, Neelima Kukreti, Abdulkarim S Binshaya
The genomic era has brought about a transformative shift in our comprehension of cancer, unveiling the intricate molecular landscape underlying disease development. Eye cancers (ECs), encompassing diverse malignancies affecting ocular tissues, pose distinctive challenges in diagnosis and management. Long non-coding RNAs (lncRNAs), an emerging category of non-coding RNAs, are pivotal actors in the genomic intricacies of eye cancers. LncRNAs have garnered recognition for their multifaceted roles in gene expression regulation and influence on many cellular processes...
January 3, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38172218/single-cell-transcriptomics-enable-the-characterization-of-local-extension-in-retinoblastoma
#12
JOURNAL ARTICLE
Yaoming Liu, Wei Hu, Yanjie Xie, Junjie Tang, Huan Ma, Jinmiao Li, Jiahe Nie, Yinghao Wang, Yang Gao, Chao Cheng, Cheng Li, Yujun Ma, Shicai Su, Zhihui Zhang, Yuekun Bao, Yi Ren, Xinyue Wang, Fengyu Sun, Shengli Li, Rong Lu
Retinoblastoma (RB) is the most prevalent ocular tumor of childhood, and its extraocular invasion significantly increases the risk of metastasis. Nevertheless, a single-cell characterization of RB local extension has been lacking. Here, we perform single-cell RNA sequencing on four RB samples (two from intraocular and two from extraocular RB patients), and integrate public datasets of five normal retina samples, four intraocular samples, and three extraocular RB samples to characterize RB local extension at the single-cell level...
January 3, 2024: Communications Biology
https://read.qxmd.com/read/38146007/comparative-study-on-genomic-and-epigenomic-profiles-of-retinoblastoma-or-tuberous-sclerosis-complex-via-nanopore-sequencing-and-a-joint-screening-framework
#13
JOURNAL ARTICLE
Junting Wang, Chengyue Zhang, Li Zhang, Hong-Juan Yao, Xiaohong Liu, Yuchen Shi, Junyang Zhao, Xiaochen Bo, Hebing Chen, Liang Li
Recurrence and extraocular metastasis in advanced intraocular retinoblastoma (RB) are still major obstacles for successful treatment of Chinese children. Tuberous sclerosis complex (TSC) is a very rare, multisystemic genetic disorder characterized by hamartomatous growth. In this study, we aimed to compare genomic and epigenomic profiles with human RB or TSC using recently developed nanopore sequencing, and to identify disease-associated variations or genes. Peripheral blood samples were collected from either RB or RB/TSC patients plus their normal siblings, followed by nanopore sequencing and identification of disease-specific structural variations (SVs) and differentially methylated regions (DMRs) by a systematic biology strategy named as multiomics-based joint screening framework...
December 25, 2023: Cancer Gene Therapy
https://read.qxmd.com/read/38109867/emerging-role-of-circular-rnas-in-the-pathogenesis-of-retinoblastoma
#14
REVIEW
Weizhen Wu, Youjing Zhang, Ming Yang
Retinoblastoma (Rb) accounts for 3% of all childhood cancers. It is the most common intraocular malignant tumor with a highly aggressive and metastatic phenotype. Gaining a more comprehensive understanding of the molecular mechanisms underlying the proliferation, metastasis, migration, invasive apoptosis, and autophagy processes associated with this cancer would facilitate the design of therapeutic modalities and the identification of novel tumor markers. Recent investigations have shown the contribution of circular RNAs (circRNAs) in the evolution of Rb...
2024: Ophthalmic Research
https://read.qxmd.com/read/38099390/clinicodemographic-profile-management-and-treatment-outcomes-in-advanced-retinoblastoma-at-a-tertiary-care-center-in-north-india
#15
JOURNAL ARTICLE
Sonali Vinay Kumar, Vinay Kumar, Alok Sati, Sanjay Kumar Mishra, Sanjeev Khera, Atul Mishra, Ankit Mathur, Manoj Gopinath, Aneesh Mohimen, Virender Malik, Natasha V Kumar
PURPOSE: The study was undertaken to look into the clinicodemographic profile, management, and clinical outcomes of advanced retinoblastoma at a tertiary care center. METHODS: A prospective cohort study was conducted from Jan 2019 to Dec 2022. Forty-two patients of intraocular advanced retinoblastoma were assessed. The treatment protocol was formulated based on size, extension of tumor, and laterality. Primary outcome measure was response to the treatment in terms of regression of tumor and seeds and no evidence of recurrence after 12 month in enucleated eyes...
December 15, 2023: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38090281/the-potent-novel-cdk4-6-inhibitor-tqb3616-in-hormone-receptor-positive-breast-cancer-preclinical-characterization-with-in-vitro-and-human-tumor-xenograft-models
#16
JOURNAL ARTICLE
Wenyu Hu, Lei Wang, JiaLing Luo, Jian Zhang, Nanlin Li
PURPOSE: Inhibition of the cyclin-dependent kinase (CDK) 4/6-retinoblastoma (RB) pathway exerts a considerable inhibitory effect, preventing the spread and metastasis of breast cancer cells and promoting tumor regression. In this study, we examined the antitumor activity of TQB3616, a novel inhibitor of CDK4/6 activity, which showed a greater efficacy improvement in antitumor effects. METHODS: TQB3616 group, abemaciclib group and endocrine or HER-2 targeted combination therapy group were set up respectively...
2023: Breast Cancer: Targets and Therapy
https://read.qxmd.com/read/38070170/patient-related-factors-and-clinical-management-outcomes-of-retinoblastoma-in-calabar-nigeria
#17
Elizabeth D Nkanga, Anthony C Nlemadim, Mattan Arazi, Dennis G Nkanga, Roseline E Duke, Ido D Fabian, Essemfon D Nkanga, Friday A Odey, Martin M Meremikwu
BACKGROUND: Retinoblastoma is curable in industrialized countries. However, it is associated with mortality in resource-poor nations due to disparities and poor access to eye care. Aim was to determine the relationships between patient-related factors and clinical outcomes of Retinoblastoma management in a tertiary hospital in Nigeria. MATERIALS AND METHODS: This was a retrospective study of all children who were diagnosed and treated for Retinoblastoma from January 2017 through December 2022...
December 4, 2023: West African Journal of Medicine
https://read.qxmd.com/read/38059077/metastatic-retinoblastoma-at-presentation-clinical-presentation-treatment-and-outcomes
#18
JOURNAL ARTICLE
Chandra L Kakarala, Vishal Rameshkumar Raval, Akhila Mallu, Rohit Rao, Suneetha Gavara, Vijay Anand P Reddy, Dilip K Mishra, Saumya Jakati, Swathi Kaliki
The aim of this study was to retrospectively determine clinical features, treatment outcomes, and overall survival in four patients with metastatic retinoblastoma at presentation. The mean age at diagnosis was 63 months (range: 24-108 months). Three patients had overt orbital disease of at least one eye and one patient had microscopic orbital disease with scleral infiltration on histopathology. Metastatic sites included regional lymph nodes (RLN) ( n = 4), bone marrow (BM) ( n = 2), and cerebrospinal fluid (CSF) ( n = 1)...
2023: Oman Journal of Ophthalmology
https://read.qxmd.com/read/38054123/an-interesting-case-of-post-enucleation-retinoblastoma-presenting-with-distant-liver-and-skeletal-metastases-detected-on-18f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography
#19
Ritwik Wakankar
Retinoblastomas are the most common primary ocular malignancies in the pediatric population. They are known to undergo metastasis to distant sites like the bone marrow, lymph nodes, and skeleton, but liver metastasis is rare. 18F-fluorodeoxyglucose positron emission tomography-computed tomography is an interesting imaging technique that allows for staging for disease metastasis and plays a crucial role in treatment planning and prognostication of retinoblastoma patients with suspected distant metastasis. The case report highlights this very fact by demonstrating the case of a one-year-old boy with retinoblastoma that had metastasized to the skull bones and even the liver...
November 2023: Curēus
https://read.qxmd.com/read/38024824/utility-of-bone-marrow-examination-in-retinoblastoma-and-their-correlation-with-hematological-features
#20
JOURNAL ARTICLE
Geeta Yadav, Anurag Singh, Rashmi Kushwaha, Nishant Verma, Rajat Mohan Srivastava, Uma Shankar Singh
Retinoblastoma makes up about 3% of all childhood malignancies. The frequency of metastatic retinoblastoma ranges from 4.8 to 11%. Assessing the bone marrow status of newly diagnosed patients is crucial because of the advantages of autologous bone marrow transplants for high-risk patients. This study aimed to determine the utility of bone marrow examination in cases of retinoblastoma and its correlation with hematological findings. This retrospective study was conducted at the Department of Pathology, King George's Medical University, Lucknow, India...
August 2023: Journal of Medicine and Life
keyword
keyword
120311
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.